It has really levelled off in the last little while, because we haven't had as many investigational new drug submissions come in.
The beauty of having the clinical trials done in Canada is that you really have the veterinarians engaged in the development process. That's where we are going and that's what we want to do, which is why we are bringing these people to the table.
Optimally, the objective is to be able to have these studies conducted in Canada. If veterinarians are engaged, they are the ones who would provide the recommendations to Health Canada in terms of “Sure, there's a regulatory review and approval process, but by the same token, in the real world this is how these drugs are used or may be used, and how do you reconcile that?”